The incretin–joint axis: weight-independent mechanisms and disease-modifying potential in chronic arthropathies
Clicks: 3
ID: 325561
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
0.0
/100
3 views
0 readers
AI Quality Assessment
Not analyzed
Readership in this journal
Ranked #32 of 46 articles by views in Rheumatology Advances in Practice
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Chronic arthropathies are major drivers of pain and disability, and an immunometabolic template is reshaping how osteoarthritis (OA) and inflammatory arthritis are conceptualized, linking systemic metabolic stress to synovial inflammation, cartilage catabolism, and disease progression. Incretin-based therapies (GLP-1RAs and dual GLP-1R/GIPR agonists) have revealed pleiotropic actions extending beyond weight loss and glycaemic control, supporting the concept of an “incretin–joint axis” with disease-modifying potential. Joint tissues appear capable of sensing incretin signalling, supporting a direct, receptor-mediated action within the joint. Across articular cell types, GLP-1RA exposure engages conserved stress-response pathways, reducing inflammation and catabolism in chondrocytes and modulating synovial fibroblast and macrophage activity in inflammatory arthritis. Early clinical data indicate improvements in OA symptoms with GLP-1R agonism; however, mechanistic attribution remains intertwined with weight reduction. Definitive translation will require receptor-centric mapping in human joint microenvironments and interventional designs disentangling direct joint actions from weight-mediated benefit.
| Reference Key |
openalex_W7203739983
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Nefeli Stavroula Papastathopoulou, Simona Neri, Elisa Assirelli, Andrea D’Amuri, Salvatore Greco, Jacopo Ciaffi, Francesco Ursini |
| Journal | Rheumatology Advances in Practice |
| Year | 2026 |
| DOI |
10.1093/rap/rkag105
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.